Grant: Planning and Dissemination Grant - Institute Community Support
University of British Columbia
$20,000.00
CBS/CSPS-2026 Conference: Next Generation Biomaterials and Pharmaceutical Technologies for All
FY 2025-26
Summary
The Canadian Biomaterials Society (CBS) and the Canadian Society of Pharmaceutical Sciences (CSPS) are not-for-profit professional organizations dedicated to the development of biomaterials science & technology, drug development and delivery technologies, as well as education of future scientists in these areas in Canadian universities, industry, and government. The two societies are holding a joint in-person conference, marking the 40th and 28th Annual Meeting of CBS and CSPS respectively, entitled "CBS/CSPS-2026: Next Generation Biomaterials and Pharmaceutical Technologies for All" in the University of British Columbia campus from June 9-12, 2026. This event will bring together trainees, professors, clinicians, industrial partners and regulatory officials from across Canada to share their latest discoveries, progress and challenges in pharmaceutical/biomaterials research & their clinical applications. A large part of the scientific program will be focused on new generation medicines for inflammatory diseases, immune cell therapy and novel drug delivery technologies, vaccine and adjuvants, and anti-infection technologies. Furthermore, a priority workshop will be organized to provide the new biomanufacturing, immune cell therapy and manufacturing of genetic medicines by leading experts in the field. The event, provide opportunities for trainee and early career researchers for presentations, as well as building professional networks. Therefore, our event addresses the Strategic Research Priorities of the Institute of Infection and Immunity (III) and the Planning and Dissemination program objectives. The slogan "Next Generation Biomaterials and Pharmaceutical Technologies for All" was chosen to reflect our commitment to creating an inclusive meeting that celebrates and promotes Equity, Diversity and Inclusion (EDI) initiatives, and in recognition of the importance of biological sex and other population considerations in biomaterials and pharmaceutical research.
Department
Program
Planning and Dissemination Grant - Institute Community Support
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
531324
Name
Kizhakkedathu Jayachandran N
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Planning and Dissemination Grants
Projecttitle
CBS/CSPS-2026 Conference: Next Generation Biomaterials and Pharmaceutical Technologies for All
Programtype2
Miscellaneous Programs
Orgnameinp2
University of British Columbia
Cihramount2
$20,000
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Anti-Infective Biomaterials; Canadan Pharmaceutical Sciences Annual Meeting; Canadian Biomaterials Society Annual Meeting; Conference; Dissemination; Drug Delivery; Immunomodulation; Inflammation; Knowledge Translation; Therapeutics
Abstract
The Canadian Biomaterials Society (CBS) and the Canadian Society of Pharmaceutical Sciences (CSPS) are not-for-profit professional organizations dedicated to the development of biomaterials science & technology, drug development and delivery technologies, as well as education of future scientists in these areas in Canadian universities, industry, and government. The two societies are holding a joint in-person conference, marking the 40th and 28th Annual Meeting of CBS and CSPS respectively, entitled "CBS/CSPS-2026: Next Generation Biomaterials and Pharmaceutical Technologies for All" in the University of British Columbia campus from June 9-12, 2026. This event will bring together trainees, professors, clinicians, industrial partners and regulatory officials from across Canada to share their latest discoveries, progress and challenges in pharmaceutical/biomaterials research & their clinical applications. A large part of the scientific program will be focused on new generation medicines for inflammatory diseases, immune cell therapy and novel drug delivery technologies, vaccine and adjuvants, and anti-infection technologies. Furthermore, a priority workshop will be organized to provide the new biomanufacturing, immune cell therapy and manufacturing of genetic medicines by leading experts in the field. The event, provide opportunities for trainee and early career researchers for presentations, as well as building professional networks. Therefore, our event addresses the Strategic Research Priorities of the Institute of Infection and Immunity (III) and the Planning and Dissemination program objectives. The slogan "Next Generation Biomaterials and Pharmaceutical Technologies for All" was chosen to reflect our commitment to creating an inclusive meeting that celebrates and promotes Equity, Diversity and Inclusion (EDI) initiatives, and in recognition of the importance of biological sex and other population considerations in biomaterials and pharmaceutical research.
Competitiondate
202506
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kizhakkedathu, Jayachandran N
Approvedterm
1 an 0 mois
Cihrcontribution2
III~ $20,000~ $0~